1.	FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: DERMATUX, NCT01315990
2.	Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: AIO-KRK-0207, ML21768, EudraCT-Nr.: 2008-007974-39, NCT00973609
3.	Folic Acid Clinical Trial for the Prevention of Cervical Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: CDR0000579360, UAB-F060511015, UAB-IRB0000196, F060511015, NCT00703196
4.	Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: UOSG-AMC-0804, NCT01490437
5.	A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010/VCC/0049, 2010-023230-22, NCT01569919